Patents by Inventor Keitaro MATSUYAMA
Keitaro MATSUYAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11878101Abstract: A blood purification device includes a porous molded body containing an inorganic ion-adsorbing material and is characterized by the following: the concentrations of Mg, Al, Ti, V, Cr, Mn, Fe, Ni, Cu, Zn, Ga, Rb, Sr, Y, Zr, Mo, Ru, Ag, Cd, Sn, Cs, La, Pr, Sm, Gd, Tb, Ta, Au, Tl, Co, In, and Bi are each 0.1 ppb or less and the concentrations of Ba, Nd, Pb, And Ce are each 1 ppb or less in a physiological saline solution for injection both three months and six months after said physiological saline solution for injection is sealed in the blood purification device; and the number of fine particles having a size of 10 ?m or more is 25 or less and the number of fine particles having a size of 25 ?m or more is 3 or less in 1 mL of the physiological saline solution for injection.Type: GrantFiled: March 29, 2019Date of Patent: January 23, 2024Assignee: ASAHI KASEI MEDICAL CO., LTD.Inventors: Teruhiko Oishi, Makoto Ozeki, Keitaro Matsuyama, Naoki Morita, Hiroshi Tajima, Toshinori Koizumi
-
Patent number: 11806461Abstract: Provided is a blood purification device including a porous molded body that has a high phosphorus adsorption capacity and that can be used safely. A blood purification device includes a porous molded body containing an inorganic ion-adsorbing material and is characterized by the following: said blood purification device satisfies the relationship B=?0.02 A+2.175±0.185 (74?A?94) when the moisture content of the porous molded body is denoted by A and the bulk density is denoted by B; and the number of fine particles having a size of 10 ?m or more is 25 or less and the number of fine particles having a size of 25 ?m or more is 3 or less in 1 mL of a physiological saline solution for injection both three months and six months after said physiological saline solution for injection is sealed in the blood purification device.Type: GrantFiled: March 29, 2019Date of Patent: November 7, 2023Assignee: ASAHI KASEI MEDICAL CO., LTD.Inventors: Teruhiko Oishi, Naoki Morita, Keitaro Matsuyama, Hiroshi Tajima, Toshinori Koizumi
-
Publication number: 20220168490Abstract: Provided is a blood purifier which has a porous molded body with good phosphorus adsorption, which has good cytokine adsorption performance, no hemolysis, and can be used safely. The blood purifier has a porous molded body having a low-melting-point moisture content per gram of dry weight of 0.12 g or more and 1.35 g or less. After three and six months from sealing of a saline solution for injection into the blood purifier, the number of microparticles greater than or equal to 10 ?m is 25 or less and the number of microparticles greater than or equal to 25 ?m is three or less in 1 mL of the saline solution for injection.Type: ApplicationFiled: March 27, 2020Publication date: June 2, 2022Applicant: ASAHI KASEI MEDICAL CO., LTD.Inventors: Teruhiko OISHI, Yusuke TOKIMIZU, Keitaro MATSUYAMA, Naoki MORITA
-
Publication number: 20220111133Abstract: A blood purifier includes a porous molded body; exhibits an excellent blood compatibility wherein platelet adherence is inhibited and exhibits a good cytokine adsorption capacity and a low pressure loss before and after blood treatment; and can be safely used. A blood purifier includes a main vessel and a porous molded body housed in the main vessel. The porous molded body contains a hydrophobic polymer and a hydrophilic polymer. The amount of low-melting-point water per 1 g of dry weight of the porous molded body is 0.12 g to 2.00 g. The contact change ratio for the porous molded body is 0% to 0.2%. The ratio L/D is 1.00 to 2.30 where, for the region taken up by the porous molded body in the main vessel, L is the length in the flow direction and D is the circle-equivalent diameter of the cross section in the direction perpendicular to the flow direction.Type: ApplicationFiled: March 27, 2020Publication date: April 14, 2022Applicant: Asahi Kasei Medical Co., Ltd.Inventors: Teruhiko OISHI, Yusuke TOKIMIZU, Keitaro MATSUYAMA, Naoki MORITA
-
Publication number: 20220105454Abstract: Provided is a blood purifier which includes a porous formed body and which has excellent blood compatibility, in which platelets are unlikely to adhere, has good cytokine adsorption capacity, and low pressure loss before and after treating blood, and can be safely used. Disclosed is a blood purifier having a body container, and a porous formed body accommodated in the body container. The porous formed body contains a hydrophobic polymer and a hydrophilic polymer, the low-melting-point water content per 1 g of dry weight of the porous formed body is 0.12-2.00 g, the rate of contact change of the porous formed body is 0-0.2%, and the adhering amount of platelets per 1 mL of blood is 0.400 billion/mL or less when brining the blood into contact with the porous formed body.Type: ApplicationFiled: March 27, 2020Publication date: April 7, 2022Applicant: ASAHI KASEI MEDICAL CO., LTD.Inventors: Teruhiko OISHI, Yusuke TOKIMIZU, Keitaro MATSUYAMA, Naoki MORITA
-
Publication number: 20210353845Abstract: Provided is a blood purification device including a porous molded body that has a high phosphorus adsorption capacity and that can be used safely. A blood purification device includes a porous molded body containing an inorganic ion-adsorbing material and is characterized by the following: said blood purification device satisfies the relationship B=?0.02 A+2.175±0.185 (74?A?94) when the moisture content of the porous molded body is denoted by A and the bulk density is denoted by B; and the number of fine particles having a size of 10 ?m or more is 25 or less and the number of fine particles having a size of 25 ?m or more is 3 or less in 1 mL of a physiological saline solution for injection both three months and six months after said physiological saline solution for injection is sealed in the blood purification device.Type: ApplicationFiled: March 29, 2019Publication date: November 18, 2021Applicant: ASAHI KASEI MEDICAL CO., LTD.Inventors: Teruhiko OISHI, Naoki MORITA, Keitaro MATSUYAMA, Hiroshi TAJIMA, Toshinori KOIZUMI
-
Publication number: 20210008270Abstract: A blood purification device includes a porous molded body containing an inorganic ion-adsorbing material and is characterized by the following: the concentrations of Mg, Al, Ti, V, Cr, Mn, Fe, Ni, Cu, Zn, Ga, Rb, Sr, Y, Zr, Mo, Ru, Ag, Cd, Sn, Cs, La, Pr, Sm, Gd, Tb, Ta, Au, Tl, Co, In, and Bi are each 0.1 ppb or less and the concentrations of Ba, Nd, Pb, And Ce are each 1 ppb or less in a physiological saline solution for injection both three months and six months after said physiological saline solution for injection is sealed in the blood purification device; and the number of fine particles having a size of 10 ?m or more is 25 or less and the number of fine particles having a size of 25 ?m or more is 3 or less in 1 mL of the physiological saline solution for injection.Type: ApplicationFiled: March 29, 2019Publication date: January 14, 2021Applicant: ASAHI KASEI MEDICAL CO., LTD.Inventors: Teruhiko OISHI, Makoto OZEKI, Keitaro MATSUYAMA, Naoki MORITA, Hiroshi TAJIMA, Toshinori KOIZUMI